Literature DB >> 201410

Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome.

D T Purtilo, L Hutt, J Bhawan, J P Yang, C Cassel, S Allegra, F S Rosen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 201410     DOI: 10.1016/0090-1229(78)90066-1

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  13 in total

Review 1.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

2.  Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells.

Authors:  E E Henderson; W K Long; R Ribecky
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

Review 3.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

Review 4.  Lymphocyte function and disease.

Authors:  A M Denman
Journal:  Br Med J       Date:  1978-10-07

5.  Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

Authors:  P K Pattengale; C R Taylor
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

6.  Selective immunodeficiency and malignant lymphoma of the central nervous system. Possible relationship to the Epstein-Barr virus.

Authors:  P K Pattengale; C R Taylor; T Panke; D Tatter; R A McCormick; D G Rawlinson; R L Davis
Journal:  Acta Neuropathol       Date:  1979-12       Impact factor: 17.088

7.  Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue.

Authors:  J K Murphy; L S Young; I S Bevan; F A Lewis; D Dockey; J W Ironside; C J O'Brien; M Wells
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

8.  Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.

Authors:  N Yasuda; P K Lai; J Rogers; D T Purtlo
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

9.  Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

Authors:  G R Nemerow; F C Jensen; N R Cooper
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia.

Authors:  A K Saemundsen; A I Berkel; W Henle; G Henle; M Anvret; O Sanal; F Ersoy; M Cağlar; G Klein
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.